chlorine and levodopa
chlorine has been researched along with levodopa in 15 studies
Research
Studies (15)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (20.00) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Devereaux, MW; Mancall, EL | 1 |
Eisenlohr, JJ; Gehlen, W | 1 |
Galindo, JD; Iborra, JL; Lozano, JA; Pedreño, E; Peñafiel, R; Solano, F | 1 |
Beal, MF; Calne, DB; Good, PF; Hewitt, KA; Olanow, CW; Perl, DP; Shinotoh, H; Snow, BJ; Vingerhoets, F | 1 |
Baker, D; Dawson, R; Eppler, B; Hern, H; Hu, M; Shih, D; Tang, E | 1 |
Delogu, MR; Desole, MS; Enrico, P; Esposito, G; Grella, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, PA | 1 |
Burkhardt, K; Ludolph, AC; Schwarz, J; Storch, A | 1 |
Beauregard, M; Chapados, C; Gélinas, S; Gosselin, I; Martinoli, MG | 1 |
Blunt, SB; Datla, KP; Dexter, DT | 1 |
Bubacco, L; Canters, GW; Tepper, AW | 1 |
Biasetti, M; Dawson, R | 1 |
Anaya-Martinez, V; Avila-Costa, MR; Corona, DR; Gutierrez-Valdez, AL; Martinez-Fong, D; Montiel-Flores, E; Ordoñez-Librado, JL | 1 |
Hormozi-Nezhad, MR; Khodaveisi, J; Tashkhourian, J | 1 |
Chen, J; Huang, JY; Jin, H; Liu, CF; Mao, CJ; Wang, F; Xu, LL; Yang, Y; Yang, YP; Zhang, HJ; Zhang, JR; Zhong, CK | 1 |
Banks, CE; Crapnell, RD; Whittingham, MJ | 1 |
Other Studies
15 other study(ies) available for chlorine and levodopa
Article | Year |
---|---|
Letter: Brown urine, bleach, and L-dopa.
Topics: Chlorine; Color; Dopamine; Humans; Levodopa; Male; Parkinson Disease; Toilet Facilities; Urine | 1974 |
[Changes of blood pressure, pulse and electrolytes following long-term treatment of Parkinsonism using Ro 8-0576 (L-Dopa and decarboxylase inhibitor)].
Topics: Aged; Antiparkinson Agents; Arrhythmias, Cardiac; Blood Pressure; Blood Pressure Determination; Calcium; Carboxy-Lyases; Chlorides; Drug Combinations; Electrolytes; Female; Humans; Hypotension; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease; Potassium; Pulse; Sodium | 1975 |
Kinetic study of the interaction between frog epidermis tyrosinase and chloride.
Topics: Animals; Bromides; Catechol Oxidase; Chlorides; Epidermis; Fluorides; Hydrogen-Ion Concentration; Iodides; Kinetics; Levodopa; Mathematics; Monophenol Monooxygenase; Rana esculenta; Skin | 1984 |
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
Topics: Animals; Basal Ganglia; Brain; Carbidopa; Chlorides; Gliosis; Globus Pallidus; Levodopa; Macaca mulatta; Male; Manganese Compounds; Manganese Poisoning; Parkinson Disease, Secondary; Poisoning; Substantia Nigra | 1996 |
Taurine inhibition of iron-stimulated catecholamine oxidation.
Topics: Animals; Antioxidants; Catecholamines; Chlorides; Ferric Compounds; Iron; Kidney; Levodopa; LLC-PK1 Cells; Male; Oxidation-Reduction; Rats; Rats, Inbred F344; Swine; Taurine | 1998 |
Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Chlorides; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis Solutions; Dopamine; Homovanillic Acid; Infusion Pumps; Levodopa; Male; Manganese; Manganese Compounds; Microdialysis; Movement; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Wistar; Time Factors; Uric Acid | 2000 |
Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Animals; Cell Survival; Cells, Cultured; Chlorides; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Ferric Compounds; Humans; Levodopa; Lipid Peroxidation; Neuroglia; Neurons; Oxidative Stress; Oxidopamine; Rats; Riluzole | 2000 |
Effect of oxidative stress on stability and structure of neurofilament proteins.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Chlorides; Circular Dichroism; Dopamine; Electrophoresis, Polyacrylamide Gel; Ferric Compounds; Free Radicals; Levodopa; Molecular Weight; Neurofilament Proteins; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Protein Structure, Secondary; Spectroscopy, Fourier Transform Infrared; Swine | 2000 |
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Chlorides; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ferric Compounds; Immunoenzyme Techniques; Levodopa; Male; Neostriatum; Nerve Net; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |
Structural basis and mechanism of the inhibition of the type-3 copper protein tyrosinase from Streptomyces antibioticus by halide ions.
Topics: Chlorides; Copper; Fluorides; Hydrogen-Ion Concentration; Levodopa; Magnetic Resonance Spectroscopy; Monophenol Monooxygenase; Streptomyces antibioticus | 2002 |
Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation.
Topics: Amino Acids, Sulfur; Catecholamines; Chlorides; Ferric Compounds; Levodopa; Molsidomine; Nitric Oxide; Nitroprusside; Norepinephrine; Oxidation-Reduction; Taurine | 2002 |
L-DOPA treatment reverses the motor alterations induced by manganese exposure as a Parkinson disease experimental model.
Topics: Acetates; Administration, Inhalation; Animals; Antiparkinson Agents; Chlorides; Corpus Striatum; Disease Models, Animal; Dopamine; Levodopa; Male; Manganese Compounds; Mice; Motor Activity; Organometallic Compounds; Parkinson Disease | 2010 |
Application of silver nanoparticles and principal component-artificial neural network models for simultaneous determination of levodopa and benserazide hydrochloride by a kinetic spectrophotometric method.
Topics: Benserazide; Calibration; Chemistry; Chlorides; Hydrogen-Ion Concentration; Kinetics; Levodopa; Metal Nanoparticles; Models, Chemical; Nanotechnology; Neural Networks, Computer; Principal Component Analysis; Silver; Software | 2011 |
Serum sodium and chloride are inversely associated with dyskinesia in Parkinson's disease patients.
Topics: Age of Onset; Aged; Antiparkinson Agents; Chlorides; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sodium; Time Factors | 2017 |
Additively Manufactured Rotating Disk Electrodes and Experimental Setup.
Topics: Acrylonitrile; Butadienes; Carbon; Chlorides; Electrodes; Levodopa; Polyesters; Soot; Styrenes | 2022 |